Yasemin Altuner Torun

Yasemin Altuner Torun

Auto-generated profile, based on publicly available information

Yasemin Altuner Torun

Division of Pediatric Hematology, Department of Pediatrics, İstinye University School of Medicine, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2016 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
YTY. Altuner Torun
Y. Altuner Torun
UEU. Ertural
U. Ertural
AEA. B. Ergul
A. B. Ergul
CKCigdem Karakukcu
Cigdem Karakukcu
MAM. A. Akin
M. A. Akin
Objective: Indirect bilirubin exerts an antioxidant effect when increased mildly. This study aimed to investigate whether increased bilirubin levels lead to an oxidant effect in newborns with hyperbilirubinemia requiring phototherapy. Patients and methods: The study included 30 term newborn infants aged 0–7 days with indirect hyperbilirubinemia requiring phototherapy and no comorbid disease as the study group. In addition, 30 term healthy newborn infants aged 0–7 days without indirect hyperbilirubinemia were employed as a control group. Serum triglyceride, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), serum paraoxonase (PON) levels and malondialdehyde (MDA) levels were compared between the groups. Results: Serum MDA, total bilirubin, and LDL and HDL levels were significantly higher and the serum PON level was significantly lower, in the study group compared with the controls (p < 0.05). Conclusion: In newborns with hyperbilirubinemia requiring phototherapy, an increased bilirubin level causes oxidative stress by decreasing the level of serum PON and increasing the level of MDA.

22 May 2024 in Pediatric Nephrology
Verified
Journal Article
Open access
PDF file
MSMehmet Sabanci
Mehmet Sabanci
MTMehmet Taşdemir
Mehmet Taşdemir
BÖBurcu Öksüz
Burcu Öksüz
YTYasemin Altuner Torun
Yasemin Altuner Torun
MSMurat Sütçü
Murat Sütçü
OÖOzan Özkaya
Ozan Özkaya
A 13-year-old girl who had a kidney transplant four weeks prior presented with a 10-day history of fatigue, paleness, and headache. On physical examination, tachycardia and paleness were noted. Laboratory testing was notable for severe anemia and mild leukopenia and thrombocytopenia. Polymerase chain reaction (PCR) test for Epstein-Barr virus (EBV) and cytomegalovirus (CMV) were negative and for parvovirus B19 (PVB19) was positive. Despite lower immunosuppression and administration of intravenous immunoglobulin (IVIG) it persisted for 15 months, and frequent red blood cell transfusions were needed. PVB19 is a less common but significant complication. The patient's clinical course demonstrates the importance of this complication and the challenges in its management. A notable void exists in the literature regarding standardized treatment protocols for PVB19-induced recurrent anemia after kidney transplant. This case indicates the need for further research and consensus to guide effective clinical interventions in similar cases.